Association between circulating leptin levels and multiple sclerosis: a systematic review and meta-analysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Postgraduate medical journal

• Publication date

  2018-03-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/postgradmedj-2017-135397PMID 29581230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leptin and autoimmune disease.

  2017cited by this paper
• Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.

  2016cited by this paper
• Hyperinsulinemia in newly diagnosed patients with multiple sclerosis

  2015cited by this paper
• Serum Leptin Levels in Treatment-Naive Patients with Clinically Isolated Syndrome or Relapsing-Remitting Multiple Sclerosis

  2014cited by this paper
• Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease

  2013cited by this paper
• Increased leptin and A-FABP levels in relapsing and progressive forms of MS

  2013cited by this paper
• Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion

  2013cited by this paper
• The relation between peptide hormones and sex hormone in patients with multiple sclerosis

  2013cited by this paper
• Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis.

  2012cited by this paper
• Leptin as an immunomodulator.

  2012cited by this paper
• Accelerated Atherosclerosis in Rheumatoid Arthritis: Rationale for Mannose-binding Lectins?

  2010cited by this paper
• Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

  2010cited by this paper
• The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?

  2008cited by this paper
• Multiple sclerosis

  2008cited by this paper
• A key role of leptin in the control of regulatory T cell proliferation.

  2007cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis.

  2007cited by this paper
• Leptin Is a Link between Adipose Tissue and Inflammation

  2006cited by this paper
• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  2005cited by this paper
• Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells.

  2005cited by this paper
• The weight of leptin in immunity

  2004cited by this paper
• Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.

  2004cited by this paper
• Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

  2001cited by this paper
• Leptin

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Crystal structure of the obese protein Ieptin-E100

  1997cited by this paper
• Immune-neuro-endocrine interactions: facts and hypotheses.

  1996cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1995cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1994cited by this paper

• Leptin as a Potential Modifier of Neuroinflammation: Contrasting Roles in Alzheimer’s Disease and Multiple Sclerosis

  2025cites this paper
• Relationship between serum levels of folic acid and homocysteine with cognitive impairment in patients diagnosed with multiple sclerosis

  2024cites this paper
• Protein biomarkers in multiple sclerosis

  2023cites this paper
• Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations

  2022cites this paper
• Metabolic syndrome parameters and multiple sclerosis disease outcomes: A Portuguese cross-sectional study.

  2022cites this paper
• Association of Leptin and Adiponectin with Magnetic Resonance Imaging in Multiple Sclerosis Patients

  2021cites this paper
• Serum levels of leptin and adiponectin in patients with multiple sclerosis

  2021cites this paper
• Investigation of blood leptin and adropin levels in patients with multiple sclerosis

  2021cites this paper
• Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment

  2021cites this paper
• THE CORRELATION BETWEEN SERUM TEF3 AND SERUM SFRP5, KLOTHO, GALECTIN-3, AND NESFATIN-1 IN PATIENTS WITH DIABETIC NEPHROPATHY

  2021cites this paper
• Increased leptin-b expression and metalloprotease expression contributed to the pyridoxine-associated toxicity in zebrafish larvae displaying seizure-like behavior.

  2020cites this paper
• Leptin levels are associated with multiple sclerosis risk

  2020cites this paper
• Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait.

  2019cites this paper